113 related articles for article (PubMed ID: 10102917)
1. Within- and between-subject variation in commonly measured anthropometric and biochemical variables.
Widjaja A; Morris RJ; Levy JC; Frayn KN; Manley SE; Turner RC
Clin Chem; 1999 Apr; 45(4):561-6. PubMed ID: 10102917
[TBL] [Abstract][Full Text] [Related]
2. Determinants of within-subject variation of fasting serum leptin concentrations in healthy subjects.
Widjaja A; Levy JC; Morris RJ; Frayn KN; Humphreys SM; Horn R; von zur Mühlen A; Turner RC; Brabant G
Exp Clin Endocrinol Diabetes; 2000; 108(3):208-13. PubMed ID: 10926318
[TBL] [Abstract][Full Text] [Related]
3. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
Yajnik CS; Shelgikar KM; Naik SS; Kanitkar SV; Orskov H; Alberti KG; Hockaday TD
Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331
[TBL] [Abstract][Full Text] [Related]
4. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
5. Pulsatile rather than continuous glucagon infusion leads to greater metabolic derangements in insulin-dependent diabetic subjects.
Paolisso G; Sgambato S; Giunta R; Varricchio M; D'Onofrio F
Diabete Metab; 1990; 16(1):42-7. PubMed ID: 2332096
[TBL] [Abstract][Full Text] [Related]
6. Effect of near physiologic insulin therapy on hypoglycemia counterregulation in type-1 diabetes.
Bischof MG; Bernroider E; Ludwig C; Kurzemann S; Kletter K; Waldhäusl W; Roden M
Horm Res; 2001; 56(5-6):151-8. PubMed ID: 11910200
[TBL] [Abstract][Full Text] [Related]
7. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
Boden G; Chen X
Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559
[TBL] [Abstract][Full Text] [Related]
8. Lipid-dependent control of hepatic glycogen stores in healthy humans.
Stingl H; Krssák M; Krebs M; Bischof MG; Nowotny P; Fürnsinn C; Shulman GI; Waldhäusl W; Roden M
Diabetologia; 2001 Jan; 44(1):48-54. PubMed ID: 11206411
[TBL] [Abstract][Full Text] [Related]
9. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
[TBL] [Abstract][Full Text] [Related]
10. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
Igawa K; Mugavero M; Shiota M; Neal DW; Cherrington AD
Diabetes; 2002 Oct; 51(10):3033-42. PubMed ID: 12351444
[TBL] [Abstract][Full Text] [Related]
11. Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue.
Samra JS; Clark ML; Humphreys SM; MacDonald IA; Bannister PA; Frayn KN
J Clin Endocrinol Metab; 1998 Feb; 83(2):626-31. PubMed ID: 9467584
[TBL] [Abstract][Full Text] [Related]
12. The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level.
Castillo MJ; Scheen AJ; Lefèbvre PJ
J Clin Endocrinol Metab; 1996 May; 81(5):1975-8. PubMed ID: 8626867
[TBL] [Abstract][Full Text] [Related]
13. Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM.
Torlone E; Pampanelli S; Lalli C; Del Sindaco P; Di Vincenzo A; Rambotti AM; Modarelli F; Epifano L; Kassi G; Perriello G; Brunetti P; Bolli G
Diabetes Care; 1996 Sep; 19(9):945-52. PubMed ID: 8875087
[TBL] [Abstract][Full Text] [Related]
14. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W
Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
[TBL] [Abstract][Full Text] [Related]
15. Effect of added fat on plasma glucose and insulin response to ingested potato in individuals with NIDDM.
Gannon MC; Ercan N; Westphal SA; Nuttall FQ
Diabetes Care; 1993 Jun; 16(6):874-80. PubMed ID: 8325201
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
17. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.
Basu R; Basu A; Nielsen M; Shah P; Rizza RA
J Clin Endocrinol Metab; 1999 Jul; 84(7):2314-9. PubMed ID: 10404795
[TBL] [Abstract][Full Text] [Related]
18. Acute metabolic responses of postpartal dairy cows to subcutaneous glucagon injections, oral glycerol, or both.
Osman MA; Allen PS; Mehyar NA; Bobe G; Coetzee JF; Koehler KJ; Beitz DC
J Dairy Sci; 2008 Sep; 91(9):3311-22. PubMed ID: 18765590
[TBL] [Abstract][Full Text] [Related]
19. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Giugliano D; Luyckx AS; Lefebvre PJ
Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
[TBL] [Abstract][Full Text] [Related]
20. Hormonal and metabolic responses to maintained hyperglycemia during prolonged exercise.
MacLaren DP; Reilly T; Campbell IT; Hopkin C
J Appl Physiol (1985); 1999 Jul; 87(1):124-31. PubMed ID: 10409566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
